OPPM
IBB icon

Opus Point Partners Management’s iShares Biotechnology ETF IBB Stock Holding History

Opus Point Partners Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-37,500
Closed -$3.88M – 65
2017
Q2 		$3.88M Buy
+37,500
New +$3.69M 3.55% 10

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Opus Point Partners Management's IBB Position: Q3 2019 in Review

Opus Point Partners Management held its iShares Biotechnology ETF (IBB) position steady in Q3 2019 at 125,000 shares worth $12.4M. The position accounts for 22.48% of the portfolio, ranked #1.

Opus Point Partners Management first reported a position in IBB in Q3 2015 and has held it in 15 quarters since. The position peaked at $14M in Q1 2019. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

  • Opus Point Partners Management held 125,000 shares of iShares Biotechnology ETF worth $12.4M as of Q3 2019.
  • Opus Point Partners Management left its iShares Biotechnology ETF share count unchanged in Q3 2019.
  • iShares Biotechnology ETF made up 22.48% of Opus Point Partners Management's portfolio in Q3 2019, its #1 holding.
  • Opus Point Partners Management first reported a position in iShares Biotechnology ETF in Q3 2015 and has held it in 15 quarters since.
  • Opus Point Partners Management's iShares Biotechnology ETF position peaked at $14M in Q1 2019.
  • 597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.